Only half of pregnant women worldwide who need a treatment developed over 50 years ago to prevent Rh disease--an often-fatal condition in fetuses and newborns that is now exceedingly rare in the ...
NEW YORK, NY (Aug. 10) -- Only half of pregnant women worldwide who need a treatment developed over 50 years ago to prevent Rh disease--an often-fatal condition in fetuses and newborns that is now ...
NEW YORK - A blood mismatch between a pregnant woman and her fetus may double the risk of schizophrenia, according to the results of a new study. But all of the children in the study were born before ...
In March, the U.S. FDA reported a major shortage of Rhogam, the anti-D immune globulin most widely used to prevent Rh factor incompatibility in pregnancy. Without treatment, second and subsequent ...
Only half of pregnant women worldwide who need a 50-year-old treatment that prevents an often-fatal disease in fetuses and newborns receive it, researchers have found. Only half of pregnant women ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results